US Broker Ratings

Bio-Techne Corp (TECH) Stock Analysis: Navigating a Steady Path in the Biotech Sector

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the biotechnology industry, is garnering attention from investors seeking stability in the healthcare sector. With a market capitalization of $11.35 billion, this..

BridgeBio Pharma, Inc. (BBIO): Potential 62.22% Upside Amid Robust Revenue Growth and Analyst Confidence

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is capturing the attention of investors with its significant potential upside of 62.22%, according to analyst ratings. This Palo Alto-based biotechnology company focuses on developing..

Telix Pharmaceuticals Limited (TLX): Investor Outlook Reveals 87% Upside Potential

Telix Pharmaceuticals Limited (ASX: TLX), a burgeoning player in the biotechnology sector, offers a promising investment opportunity with significant upside potential. This Australian-based biopharmaceutical company specializes in developing therapeutic and..

Ascendis Pharma A/S (ASND): Investor Outlook Reveals 34% Potential Upside

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical company, is capturing investor attention with its impressive growth metrics and promising analyst ratings. Positioned within the dynamic biotechnology industry, Ascendis Pharma..

Bruker Corporation (BRKR) Stock Analysis: Navigating Growth and Market Sentiments with a $9.64 Billion Valuation

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector with a focus on medical devices, has caught the attention of investors with its robust market capitalization of $9.64..

Axsome Therapeutics (AXSM) Stock Analysis: A 58.79% Upside Potential in CNS Disorder Treatments

Axsome Therapeutics, Inc. (AXSM), a trailblazer in the biopharmaceutical realm, is making waves with its promising portfolio targeting central nervous system (CNS) disorders. Headquartered in New York, this biotech player..

Johnson & Johnson (JNJ) Stock Analysis: Investor Outlook on a Healthcare Giant with a Potential 9% Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to attract investor attention with its solid market position and promising growth prospects. As a key player in..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 36.59% Potential Upside in the Biotech Sector

Individual investors looking for opportunities in the healthcare sector might find Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) an intriguing proposition. With a market capitalization of $11.54 billion, this biotechnology firm is..

West Pharmaceutical Services (WST): Analyst Consensus Points to 11.67% Upside Potential

West Pharmaceutical Services, Inc. (NYSE: WST), a key player in the healthcare sector specializing in medical instruments and supplies, has captured the attention of investors with its robust market presence..

Waystar Holding Corp. (WAY) Stock Analysis: Unpacking a 35.76% Upside Potential in Healthcare Tech

Waystar Holding Corp. (WAY), a prominent player in the healthcare information services sector, presents an intriguing investment opportunity with a potential upside of 35.76%. The company, headquartered in Lehi, Utah,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Understanding the 18.84% Potential Upside

Investors eyeing the healthcare sector may find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing proposition. With a market capitalization of $5.1 billion, this Utah-based company operates within the Medical..

Guardant Health, Inc. (GH) Stock Analysis: A 11% Potential Upside Amid Robust Revenue Growth

Guardant Health, Inc. (GH), a leader in precision oncology, is capturing investor interest with its impressive revenue growth and a potential upside of 11.05%. With a market capitalization of $23.86..

Prestige Consumer Healthcare (PBH): Investor Outlook Reveals 49.8% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare sector, is capturing investor attention with its robust product portfolio and promising market position. With a recent price..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genomic Revolution with a 9.40% Revenue Growth

Illumina, Inc. (NASDAQ: ILMN), a prominent player in the healthcare sector, is making waves in the diagnostics and research industry with its cutting-edge genomic analysis solutions. Headquartered in San Diego,..

BioMarin Pharmaceutical Inc. (BMRN): Investor Outlook with a Promising 60% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a stalwart in the biotechnology sector, is capturing investor attention with a compelling potential upside of 60.22%, according to the latest analyst ratings. As a..

Incyte Corporation (INCY): Investor Outlook with 11.8% Potential Upside Reveals Promising Growth in Biotech

In the ever-evolving landscape of biotechnology, Incyte Corporation (NASDAQ: INCY) stands out as a formidable player. Headquartered in Wilmington, Delaware, this biopharmaceutical powerhouse engages in the discovery, development, and commercialization..

Moderna, Inc. (MRNA) Stock Analysis: Navigating a -36.49% Potential Downside Amidst Global Vaccine Innovation

As Moderna, Inc. (NASDAQ: MRNA) continues to make headlines with its groundbreaking work in messenger RNA (mRNA) medicines, investors are closely watching the company’s financial health and market positioning. With..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring Growth Potential with a 4.42% Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, particularly within the Diagnostics & Research industry, presents an intriguing investment opportunity. With a robust market cap of..

Teleflex Incorporated (TFX) Stock Analysis: Navigating a 24.66% Potential Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $5.26 billion, the company has carved..

Tenet Healthcare Corporation (THC) Stock Analysis: Assessing a Potential 10% Upside with Strong Buy Ratings

Tenet Healthcare Corporation (NYSE: THC), a prominent player in the U.S. healthcare sector, operates a diverse array of medical facilities that include hospitals, ambulatory surgery centers, and urgent care centers...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds